Jane Street Group, LLC and affiliated entities filed Amendment No. 2 to Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of Core Scientific, Inc. common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: Jane Street Group, LLC reported 9,375,973 shares of Core Scientific common stock, representing 2.9% of the class.
  • Jane Street Capital, LLC: Reported shared voting and dispositive power over 9,181,840 shares, also representing 2.9% of the class.
  • Jane Street Global Trading, LLC: Reported shared voting and dispositive power over 194,133 shares, representing 0.1% of the class.
  • Jane Street Singapore Pte. Ltd: Reported zero shares beneficially owned and 0.0% of the class.
  • Voting structure: All reporting persons reported sole voting power and sole dispositive power of 0, with all shares held under shared voting and shared dispositive power.
  • Event date: The date of the event requiring this filing was September 30, 2026.

Jane Street Group's Schedule 13G Amendment for Core Scientific Common Stock

According to the filing, Jane Street Group, LLC, a Delaware-organized holding company, submitted Amendment No. 2 to its Schedule 13G regarding common stock of Core Scientific, Inc./tx (CUSIP 21874A106). The filing covers shares with a par value of $0.00001 per share and was triggered by an event dated September 30, 2026. The filing identifies Core Scientific's principal executive offices at 838 Walker Road, Dover, Delaware 19904.

The filing lists four reporting persons: Jane Street Group, LLC; Jane Street Capital, LLC; Jane Street Global Trading, LLC; and Jane Street Singapore Pte. Limited. Jane Street Group, LLC is classified as a parent holding company (type "HC"), with Jane Street Capital, LLC (type "BD"), Jane Street Global Trading, LLC (type "OO"), and Jane Street Singapore Pte. Limited (type "OO") identified as subsidiaries. All four entities are organized in Delaware except Jane Street Singapore Pte. Limited, which is organized in Singapore. The filing notes that the securities "were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer," as stated in the Item 10 certification.

At the aggregate level, the filing reports 9,375,973 shares beneficially owned by Jane Street Group, LLC, all held with shared voting and shared dispositive power and none with sole power of either type. The filing states this represents 2.9% of the class. Item 5 of the filing designates this as ownership of 5 percent or less of a class. All four reporting persons signed through authorized signatory Jeremy Kahn on November 6, 2026.

What Was Disclosed

Jane Street Group, LLC and three affiliates filed Amendment No. 2 to Schedule 13G disclosing aggregate beneficial ownership of 9,375,973 shares of Core Scientific, Inc. common stock, equal to 2.9% of the class, as of September 30, 2026.